The Genetic Basis for Vulnerability to Substance Abuse
Status
Conditions
Treatments
Details and patient eligibility
About
This investigation seeks to better define the genetic basis for vulnerability to substance abuse.
Full description
Dopamine (DA), a neurotransmitter helping to mediate reward and reinforcement, has been putatively linked to the development of substance abuse, alcohol abuse, and alcoholism. Identification of specific vulnerability-association alleles for receptors, other molecules within the reward mediating system, and other genes that may predispose individuals to the development of such disorders is the goal of the study.
This investigation will help elucidate the genetic underpinnings of substance abuse, potentially leading to the improved methods to diagnose those at risk and to help develop better therapeutic interventions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Substance abusers
- Allow for blood draw
Exclusion criteria
- Cognitively impaired
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal